A cDNA encoding a full-length N-methyl-Daspartate (NMDA) 
channels exhibit the high Ca2' permeability characteristic of neuronal NMDA receptors. Therefore, the cDNA clone hNRl codes for a human brain NMDA receptor subunit cognate to the rodent and murine brain NR1 subunits.
Glutamate receptors are the subject of intense investigation due to their potential central role in the function (1) and dysfunction (2) of the human brain. These excitatory amino acid receptors have been extensively characterized and classified according to pharmacology (3) . One class of these receptors, activated by N-methyl-D-aspartate (NMDA), the NMDA receptor, has received special attention based on its involvement in inducing long-term potentiation in the postsynaptic neuron, a phenomenon postulated to underlie some types of learning (4) . In addition, the high permeability of this ligand-gated channel to calcium ions increases the susceptibility of neurons to glutamate agonist-induced neurotoxicity resultant from overstimulation. Accordingly, the NMDA receptor may be implicated in mediating excitationinduced neuronal cell death associated with disorders such as stroke, epilepsy, Parkinson disease, and Alzheimer disease (2, 5) .
The electrophysiological and pharmacological properties of NMDA receptors have been characterized by patch-clamp recordings from cultured neurons (4, 6, 7) . Recently, a cDNA encoding one of its subunits was isolated from rat brain (8) .
This subunit, NMDAR1 or the murine homolog C1 (9) , when expressed in Xenopus laevis oocytes, forms NMDA receptor channels that exhibit the electrophysiological and pharmacological properties characteristic of the NMDA receptor, including agonist/antagonist specificity, glycine requirement, high Ca2+ permeability, and voltage-dependent channel blockade by extracellular Mg2 . Since the cloning of the NMDAR1 subunit, several other subunits of the NMDA receptor have been isolated, including the rodent NR2A, -B,
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and -C (10) and murine el, -2, and -3 subunits (11) . The NR2 subunits form functional NMDA receptor channels in amphibian oocytes only when coexpressed with the NR1 subunit, but heteromeric receptors display different electrophysiological properties (10) (11) (12) . Splice variants of the NMDAR1 subunit or C1 subunit cDNA have been identified (9, (13) (14) (15) (16) , indicating that the NMDAR gene undergoes extensive alternative splicing that, in turn, may contribute to the functional diversity of the receptor (1) .
The pivotal involvement of and interplay between glutamate receptors, NMDA receptors, and calcium channels in the biology and pathology of central neurons (2, 17) prompted us to clone and characterize the genes coding for members of these receptor and channel superfamilies from human brain (18, 19) . Here, we report the isolation of a full-length cDNA clone encoding a human brain NMDA receptor subunit cognate to the rodent NMDA receptor subunit 1 (8, 14, 15) and murine {1 subunit (9) and the characterization ofthe gene product after its expression in Xenopus oocytes.t MATERUILS AND METHODS Screening the Human Cortex cDNA Library. A cDNA library derived from size-selected human frontal cortex mRNA 2-4 kb in length (18, 19) was screened using aBstXI fragment from the rat NMDA receptor subunit 1 (rNRl) (8) encompassing nt 220-2345 of the coding region. The probe was labeled with digoxigenin-conjugated dUTP (Genius System, Boehringer Mannheim; ref. 20) , hybridized to filters (Hybond, Amersham) at 65°C overnight, and detected by binding of alkaline phosphatase-conjugated antibody specific for the digoxigenin hapten (20) . Bluescript SK(-) phagemids (Stratagene) were rescued from seven purified positive plaques by an in vivo excision protocol. A 1.4-kb Apa I fragment from an isolated human partial NMDA receptor cDNA, NM5 (nt -100 to 1316), was 32P-labeled and used to screen the human cortex library containing inserts >4 kb (18, 19) . Secondary and purification screenings were done by using the 1.4-kb probe and the Genius System (20) . The cDNA inserts were characterized by conventional restriction endonuclease mapping procedures. The nucleotide sequence was determined on both strands by the dideoxynucleotide chain-termination method (21) using the Sequenase sequencing kit (United States Biochemical). Nucleotide sequences were analyzed by using the Genetics Computer Group (Madison, WI) programs (22) . tThe sequence reported in this paper has been deposited in the GenBank data base (accession no. L05666).
T7 polymerase (18) . Isolated-follicle free-stage V and VI oocytes of X. laevis were injected (50 nl) with cRNA (0.4 mg/ml in diethylpyrocarbonate-treated water) and maintained as described (18, 23) . For electrophysiological measurements, oocytes (2-6 days) were transferred to the recording chamber (vol = 0.2 ml) and continuously perfused (2 ml/min) with Ca2+-Ringer solution (115 mM NaCl/2.5 mM KCI/1.8 mM CaCl2/5 mM N-tris[hydroxymethyl]-2-aminoethanesulfonic acid (TES) (pH 7.4), in the presence or absence of tested ligands (18) . Na+-free Ringer solution was 115 mM N-methylglucamine/3 mM KCI/10 mM CaCl2/5 mM TES, pH 7.4. Ba2+-Ringer solution was identical to Ca2+-Ringer solution but with 1.8 mM BaCl2 instead ofCaCl2. Stock solutions (100 mM) of N-allylnormetazocine (SKF-10,147), 7-chlorokynurenic acid, and 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX) were prepared in dimethyl sulfoxide. Phencyclidine (PCP) was dissolved in methanol. Dimethyl sulfoxide and methanol in final solutions were <0.01%.
Whole-cell currents were recorded with a conventional two-microelectrode voltage-clamp amplifier (Turbo TEC 01C, NPi Electronics, Tamm, F.R.G.) (18, 23) . Only oocytes with resting potentials c -30 mV were studied. All experiments were done at 22 ± 2°C. All processed data are reported as mean + SD with n 2 4, unless otherwise indicated.
RESULTS AND DISCUSSION
Isolation and Characterization of cDNA Clones. Hybridization screenings yielded several clones. One cDNA clone, denoted as hNR1, is 3.2 kb in length and spanned the entire coding region ofthe rat rNRl. Analysis ofthe hNR1 nucleotide sequence revealed the presence of an open reading frame of =2.7 kb, coding for a polypeptide of 885 amino acids. Sequence comparison between hNR1 and rNRl revealed that a 466-bp fragment (from nt 2587 to 3053) from the rat sequence was absent in the human sequence. Different NR1 splice variants derived from the rat brain NR1-encoding gene have been isolated (1, (13) (14) (15) (16) . hNR1 is a splice variant corresponding to the rodent NR1E species (13) . Restriction analysis of other partial cDNA clones isolated from the human library shows that they correspond to other splice variants. These results suggest that, as in rat brain, the NR1 primary transcript undergoes extensive alternative splicing in human brain.
Primary Sequence. Fig. 1 shows an alignment ofthe deduced amino acid sequences of hNRl, rNR1, and the human brain glutamate receptor 1 of the kainate subtype, denoted as HBGR1 (18) . The human brain hNRl sequence is 97% identical to the rat brain rNR1. The two sequences diverge widely starting at Q846, presumably an exon-intron splice junction. This splice site occurs -30 amino acids after the predicted fourth transmembrane segment. The resulting human sequence is 53 amino acids shorter than the rat sequence. Alignment data (25) and hydrophobicity plots (26) signal peptides are underlined; proposed transmembrane segments M1-M4 are enclosed in boxes. Residues at the Asn-598 position, which determine critical aspects of ion permeability (24) , are stippled. Triangles (v) indicate potential N-glycosylation sites for hNR1. hNRl differs from rNR1 before Q846 only in residues R14(-), L10(-), V2(-), S141, K194, L249, and L397. Standard one-letter amino acid code is used.
Y693), in accord with the proposed folding of the receptor protein within the cell membrane. At the amino acid level, sequence identity between either hNR1 or rNR1 and HBGR1 is only 23% (Fig. 1) . Sequence similarity and conservation among them are highest in the predicted transmembrane segments and in the region preceding Ml. Transmembrane segment M2 of hNRl and rNR1, considered to form the channel lining, contains an asparagine residue (N598, stippled) that determines the high Ca2+ permeability of the receptor channel (24) . The long N-terminal extracellular segment that precedes Ml is postulated to contain the agonist-binding site. Site-directed mutagenesis of charged residues in this region of the murine glutamate receptor a, subunit has disclosed the occurrence of at least three charged residues critical for L-glutamate binding (28): Glu-398, Asp-443, and Lys-445. Whereas Glu-398 is highly conserved in non-NMDA receptors but is absent in NMDA receptors (Glu-398 in HBGR1), Asp-443 and Lys-445 are identical in HBGR1 (Asp-443 and Lys-445) and in hNR1 or rNR1 (Asp-463 and Lys-465). These conserved residues may contribute to the folding motif that underlies ligand binding in NR1 receptors.
hNRI Clone Expresses Functional Homomeric Receptor Channels in X. Laevis Oocytes. Oocytes injected with cRNA synthesized from the hNR1 clone expressed NMDA-receptor channel activity ( Fig. 2A) . Inward currents were elicited upon perfusion of oocytes with glutamate receptor agonists, according to the pulse protocol displayed under the current traces. Perfusion with 100 AM L-glutamate/10 ,uM glycine (pulse ON) evoked an inward current that rapidly activates to a peak value and decays to a steady level. The L-glutamateevoked response was terminated when the agonist was washed out (pulse OFF). NMDA mimics the L-glutamateactivated responses (second and sixth pulse). Quisqualate elicited a signal of much smaller amplitude than those observed with L-glutamate or NMDA (fourth pulse). In contrast, no or negligible responses were observed when the oocyte was exposed to kainate or a-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA), specific agonists of non-NMDA receptors (3) . Glutamate (29) . L-glutamateand NMDA-evoked signals were blocked at a holding potential Vh = -80 mV by application of 100 ,uM Zn2+ (89 + 3%) or 100 ,uM Mg2+ (see Fig. 5 ) to the external bath solution. In contrast, glutamate-activated inward currents were insensitive to 50 ,uM 6-cyano-7-nitroquinoxaline, an antagonist of non-NMDA receptors (3, 18) .
PCP, the or-opioid benzomorphan SKF-10,047, and the dissociative anesthetic ketamine, all of which act on the PCP site (3), are potent blockers of homomenc hNR1 channels. PCP (200 nM), SKF-10,047 (5 ,AM), and ketamine (10 ,M) abrogated the glutamate-activated currents. The inhibitor concentrations at which the current amplitudes were 50% of the maximal response were 100 nM (n = 6) for MK-801, 100 nM (n = 6) for PCP, 0.5 AM for SKF 10,047 (n = 5), and 1 ,uM (n = 3) for ketamine. Accordingly, the ranking ofpotency and efficacy is MK-801 -PCP > SKF-10,047 > ketamine.
Together, these results indicate that the five sites recognized in NMDA receptors are contained in hNR1 homomeric NMnA receptor channels-namely, the NMDA, glycine, Mg2+, Zn2+, and PCP sites (3, 4, 7) . Thus, the ionic currents generated in oocytes expressing the hNR1 gene product display the agonist selectivity and antagonist sensitivity characteristic of the neuronal NMDA receptor (30) . L-Glutamate and NMDA are Potent Agonists of Homomeric hNRl Receptor Channels. L-glutamate and NMDA displayed the highest potency in activating hNR1 receptor channels ( Fig. 2A) . L-Glutamate-elicited responses were -2-fold larger than those evoked by NMDA (Figs. 2A and 3A) . I amplitudes were small: 4 nA s I < 60 nA, n = 92 for 100 ,uM L-glutamate. Similar observations were reported for the NR1 subunit of rodent and murine brain homologs (8, 9, 14) . In contrast, NR2 subunits from rat and mouse brain failed to assemble functional receptors when expressed in oocytes (10) (11) (12) . Interestingly, heterooligomers obtained by coexpressing NR1A with any of the NR2 subunits cloned thus far exhibit 100-fold larger glutamate-activated currents than those observed by NR1A homooligomers (10, 12) .
To assess specificity of the receptor channel encoded by hNR1, dose-response curves for L-glutamate and NMDA were determined (Fig. 3B ). The agonist concentrations at which the current amplitudes were 50% of the maximal responses (EC50) were 3.7 + 0.2 ,uM (n = 4) for L-glutamate and 25 ± 9 ,uM (n = 3) for NMDA and were best-fitted with Hill coefficients of 1.7 ± 0.4 and 1.9 ± 0.2. These values are in good agreement with those reported for the rat brain onist]n), where I denotes the peak current amplitude at a given agonist concentration, Imax is the maximal current estimated from the best fit to the above function, n is the number of ligand-binding sites, and K is the efficacy constant for the agonist concentration at which response is half-maximal (Imax/2). Other conditions as described in the legend for Fig. 2 .
homologs NR1A and NR1B (8, 14) . However, the EC50 for L-glutamate is 5-fold and 3-fold higher for the hNR1 than for the rat brain gene products NR1A and NR1B (8, 14) . Hence, the agonist efficacy of expressed homomeric NMDA receptors appears to depend on the splicing variant.
hNRl Receptor Channels are Permeable to Calcium Ions. L-Glutamate and NMDA-elicited responses are biphasic, exhibiting a transient current that rapidly decays to a steady level (Fig. 3A) . The peak current has been associated with the activation of an endogenous Ca2+-dependent chloride channel (31) resulting from calcium influx through NMDA receptors (32) . The current amplitude depends on the extracellular calcium concentration (Fig. 4) : a 10-fold increase of calcium concentration augmented both the peak and the plateau currents. In contrast, bathing the oocyte in Ba2+-Ringer solution (in the absence of Ca2+) prevents occurrence of the transient component, slightly reduces amplitude of the steady-level current (Fig. 4) , and shifts reversal potential toward more positive values (data not shown). The chloride channel blockers, flufenamic (100 ,uM) and niflumic acid (100 ,M) (32), attenuated the transient component of the L-glutamate-evoked inward currents in Ca2+-Ringer solution (data not shown) and, as in Ba2+-Ringer solution, the current reversed at positive potentials (Fig. SC) . Taken together, these results suggest that the fast desensitizing component of the L-glutamate-activated currents is accounted for, at least in part, by the activation of endogenous calcium-dependent chloride channels consequent to Ca2+ influx through hNR1 receptor channels and, therefore, indicate that homomeric hNR1 receptor channels are permeable to Ca2+, as are the natural NMDA-sensitive receptors in neurons (3, 7) . MgCl2 (Mg2+-pulse ON) attenuates the L-glutamate-elicited response and prevents further current generation as long as it remains in the external bathing medium. L-Glutamateactivated currents are restored as the magnesium is washed out (Mg2+-pulse OFF). In contrast, when the oocyte is held at -40 mV the blocking effect exerted by extracellular Mg2+ is less effective (Fig. SB) .
To rigorously assess the voltage dependence of hNR1 receptor channel blockade by Mg2+, the I-V relationship was studied (Fig. 5C ) using a ramp protocol (10 AM niflumic acid. Oocytes were held at -80 mV, perfused with agonist, and depolarized to 40 mV in 2 s (60 mV/s) using a ramp protocol (PCLAMP 5.5). Leak currents were determined in the absence of agonist and subtracted from the glutamate-activated currents. Each trace consists of 2000 points and represents the average of at least three oocytes. Other conditions were as described in the legend for Fig. 2. with a reversal potential of +20 mV (in the presence of chloride channel blockers). In the presence of Mg2+, the L-glutamate-evoked currents exhibit a conspicuous rectification ( Fig. SC) : Mg2+-induced blockade occurs only at negative potentials and decreases with membrane depolarization. As a result, the linear I-V relationship obtained in the absence of Mg2+ is transformed to a nonlinear function in its presence, features displayed by the NMDA receptor in the central nervous system (6) .
hNRl Codes for a Glutamate-Sensitive Receptor of the NMDA Subtype. The results show that the gene product encoded by the hNR1 cDNA clone expressed in amphibian oocytes reproduces the complex functional and pharmacological features characteristic of NMDA-receptor channel in neurons. Therefore, hNR1 codes for a human brain NMDA receptor subunit. Availability of cDNA clones for human brain NMDA receptors and their expression in heterologous systems thus provide a powerful system for a detailed investigation of the pharmacological properties of human brain receptors and, in combination with molecular modeling of the pore-forming structure, may provide insights toward the development of site-directed drug design.
